Phase II Study of Liposomal Irinotecan for Advanced Refractory Gastric Cancer
Clinical trial NCT06437678 · UNKNOWN
Trial details
- NCT number
- NCT06437678
- Sponsor
- Zhejiang Cancer Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-27
- Primary completion
- 2025-02-28
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.